⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IMUX News
Immunic, Inc. Common Stock
Immunic to Participate in Investor, Industry and Scientific Conferences in June
prnewswire.com
IMUX
Form 8-K
sec.gov
IMUX
Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the CMSC Annual Meeting 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis
prnewswire.com
IMUX
Form 8-K
sec.gov
IMUX
Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer
prnewswire.com
IMUX
Form 8-K
sec.gov
IMUX
Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors
prnewswire.com
IMUX
Form 8-K
sec.gov
IMUX
Immunic, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update
prnewswire.com
IMUX
Immunic to Participate in Investor and Medical Conferences in May
prnewswire.com
IMUX